Researchers have developed a polygenic risk score to analyze the link between dysfunctional endothelial and CAD. When doctors and their patients share common language in the relationship it can decrease the risk of CVD and death. Certain athletes with CVD abnormalities may be able to safely participate in competitive sports. The CardioNerds and expert faculty discuss a complicated case of ventricular tachycardia. The CardioNerds and Dr. Robert Mentz discuss the important steps in treating HF with mineralocorticoid antagonists. An increase in intestinal permeability allows gut bacteria to reach bone marrow. Transient ischemic attack (TIA) is associated with long-term cognitive decline. This structural discovery is a step toward the development of next-generation therapies to modulate LDL. Physicians leveraged a surgical technique to achieve partial cardiac denervation, reducing the incidence of POAF post-CABG. The caps on the end of chromosomes are called telomeres. Researchers aimed to determine whether a two-pill antihypertensive strategy is effective at controlling hypertension. Dr. Kevin Alexander speaks with The CardioNerds about the importance of providing swift treatment to patients with ATTR-CM. The CardioNerds, Dr. Alexander discuss how acoramidis therapy works, and details data Dr. Alexander presented at AHA 2024. Drs. Akiva Rosenzveig and Jenna Skowronski are joined by Dr. Randall Starling to discuss logical steps in HF management. After one year of therapeutic intervention, less oxidation and aggregation were detected in lipoproteins. Patient outreach with bulk ordering may result in higher lipid screening uptake than usual care. Insights from a new AHA scientific statement outline how palliative care can improve quality of life for survivors of stroke. Dr. Georgia Vasilakis Tsatiris of The CardioNerds speaks to Dr. Kevin Alexander about the impact of ATTR-CM. The CardioNerds in tandem with Dr. Clyde Yancy analyze a case of an 80-year-old man with heart failure. Supine blood pressure is correlated with a higher risk of adverse CVD risk.